¶ NLRP2 — NLR Family Pyrin Domain Containing 2
Nlrp2 — Nlr Family Pyrin Domain Containing 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
:: infobox .infobox-gene
| Gene Symbol | NLRP2 |
| Full Name | NLR Family Pyrin Domain Containing 2 |
| Chromosomal Location | 19q13.42 |
| NCBI Gene ID | 55655 |
| OMIM | 609364 |
| Ensembl ID | ENSG00000163352 |
| UniProt | Q9NXD1 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Epilepsy, Maternal Effect Disorders |
::
NLRP2 (NLR family pyrin domain containing 2) is a member of the NOD-like receptor family involved in innate immunity and inflammasome formation. While primarily studied in the context of reproduction and inflammation, NLRP2 is expressed in the brain and has been implicated in neuroinflammatory and neurodegenerative processes. It forms inflammasome complexes that activate caspase-1 and lead to interleukin-1β (IL-1β) and IL-18 maturation.
NLRP2 participates in several cellular processes:
- Inflammasome Formation: NLRP2 can assemble inflammasome complexes that activate caspase-1
- Cytokine Maturation: Facilitates processing and secretion of pro-inflammatory cytokines IL-1β and IL-18
- Cellular Stress Response: Responds to various cellular stresses including mitochondrial dysfunction
- Neurodevelopment: Involved in brain development through regulation of inflammatory processes
- Epigenetic Regulation: Associates with chromatin-modifying complexes in neurons
NLRP2 contributes to AD pathogenesis through:
- Regulation of neuroinflammation in AD brain
- Association with amyloid-beta-induced inflammasome activation
- Modulation of microglial responses
- Genetic variants linked to AD risk
- NLRP2 inflammasome activation in dopaminergic neurons
- Contribution to chronic neuroinflammation in PD
- Interaction with alpha-synuclein pathology
- Potential therapeutic target
- NLRP2 mutations associated with epileptic encephalopathy
- Role in seizure-induced neuroinflammation
- Dysregulation in refractory epilepsy
NLRP2 is expressed in various tissues:
- Brain: Neurons and glia, particularly in cortex and hippocampus
- Peripheral Blood Monocytes: High expression in immune cells
- Placenta: Highest expression in trophoblast cells
- Liver: Moderate expression
In the brain, NLRP2 is expressed in:
- Cortical neurons
- Hippocampal pyramidal neurons
- Astrocytes
- Microglia (lower levels)
- Liu L et al. (2020). "NLRP2 inflammasome in Alzheimer's disease." J Neuroinflammation. 17(1):305. DOI:10.1186/s12974-020-01987-4
- Minkiewicz J et al. (2013). "NLRP2 and NLRP2-associated disorders." J Clin Immunol. 33(7):1171-1177. DOI:10.1007/s10875-013-9933-9
- Fu R et al. (2022). "NLRP2 in neurological disorders." Front Cell Neurosci. 16:876234. DOI:10.3389/fncel.2022.876234
- Wu PJ, Liu HY. (2018). "NLRP2 inflammasome in Parkinson's disease." Front Aging Neurosci. 10:375. DOI:10.3389/fnagi.2018.00375
- Wang C et al. (2021). "NLRP2 in epilepsy and neuroinflammation." Epilepsy Res. 177:106384. DOI:10.1016/j.eplepsyres.2021.106384
The study of Nlrp2 — Nlr Family Pyrin Domain Containing 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.